These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 1919632

  • 1. A pilot study of interferon alfa-2a in combination with fluorouracil plus high-dose leucovorin in metastatic gastrointestinal carcinoma.
    Grem JL, McAtee N, Murphy RF, Balis FM, Steinberg SM, Hamilton JM, Sorensen JM, Sartor O, Kramer BS, Goldstein LJ.
    J Clin Oncol; 1991 Oct; 9(10):1811-20. PubMed ID: 1919632
    [Abstract] [Full Text] [Related]

  • 2. A pilot study of interferon alpha-2a, fluorouracil, and leucovorin given with granulocyte-macrophage colony stimulating factor in advanced gastrointestinal adenocarcinoma.
    Shapiro JD, Harold N, Takimoto C, Hamilton JM, Vaughn D, Chen A, Steinberg SM, Liewehr D, Allegra C, Monahan B, Lash A, Grollman F, Flemming D, Behan K, Johnston PG, Haller D, Quinn M, Morrison G, Grem JL.
    Clin Cancer Res; 1999 Sep; 5(9):2399-408. PubMed ID: 10499610
    [Abstract] [Full Text] [Related]

  • 3. Phase I and pharmacokinetic study of recombinant human granulocyte-macrophage colony-stimulating factor given in combination with fluorouracil plus calcium leucovorin in metastatic gastrointestinal adenocarcinoma.
    Grem JL, McAtee N, Murphy RF, Hamilton JM, Balis F, Steinberg S, Arbuck SG, Setser A, Jordan E, Chen A.
    J Clin Oncol; 1994 Mar; 12(3):560-8. PubMed ID: 8120554
    [Abstract] [Full Text] [Related]

  • 4. A pilot study of gamma-1b-interferon in combination with fluorouracil, leucovorin, and alpha-2a-interferon.
    Grem JL, McAtee N, Murphy RF, Balis FM, Cullen E, Chen AP, Hamilton JM, Steinberg SM, Quinn M, Sorensen JM, Arbuck SG, Lawrence D, Pang J, Allegra CJ.
    Clin Cancer Res; 1997 Jul; 3(7):1125-34. PubMed ID: 9815792
    [Abstract] [Full Text] [Related]

  • 5. Decreased catabolism of fluorouracil in peripheral blood mononuclear cells during combination therapy with fluorouracil, leucovorin, and interferon alpha-2a.
    Yee LK, Allegra CJ, Steinberg SM, Grem JL.
    J Natl Cancer Inst; 1992 Dec 02; 84(23):1820-5. PubMed ID: 1433371
    [Abstract] [Full Text] [Related]

  • 6. Phase II study of fluorouracil, leucovorin, and interferon alfa-2a in metastatic colorectal carcinoma.
    Grem JL, Jordan E, Robson ME, Binder RA, Hamilton JM, Steinberg SM, Arbuck SG, Beveridge RA, Kales AN, Miller JA.
    J Clin Oncol; 1993 Sep 02; 11(9):1737-45. PubMed ID: 8355041
    [Abstract] [Full Text] [Related]

  • 7. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin.
    Patt YZ, Hoque A, Lozano R, Pozdur R, Chase J, Carrasco H, Chuang V, Delpassand ES, Ellis L, Curley S, Roh M, Jones DV.
    J Clin Oncol; 1997 Apr 02; 15(4):1432-8. PubMed ID: 9193336
    [Abstract] [Full Text] [Related]

  • 8. Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis.
    Vokes EE, Ratain MJ, Mick R, McEvilly JM, Haraf D, Kozloff M, Hamasaki V, Weichselbaum RR, Panje WR, Wenig B.
    J Clin Oncol; 1993 Feb 02; 11(2):360-8. PubMed ID: 8426214
    [Abstract] [Full Text] [Related]

  • 9. A phase I study of continuous infusion 5-fluorouracil plus calcium leucovorin in combination with N-(phosphonacetyl)-L-aspartate in metastatic gastrointestinal adenocarcinoma.
    Grem JL, McAtee N, Steinberg SM, Hamilton JM, Murphy RF, Drake J, Chisena T, Balis F, Cysyk R, Arbuck SG.
    Cancer Res; 1993 Oct 15; 53(20):4828-36. PubMed ID: 8402669
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trial of weekly intensive therapy with 5-fluorouracil on two different schedules combined with interferon alpha-2a and filgrastim in patients with advanced solid tumors: Eastern Cooperative Oncology Group Study P-Z991.
    Wadler S, Atkins M, Karp D, Neuberg D, Haynes H, Dutcher JP.
    Cancer J Sci Am; 1998 Oct 15; 4(4):261-8. PubMed ID: 9689985
    [Abstract] [Full Text] [Related]

  • 15. A phase I trial of interferon alpha-2b with folinic acid and 5-fluorouracil administered by 4-hour infusion in metastatic colorectal carcinoma.
    Kreuser ED, Hilgenfeld RU, Matthias M, Hoksch B, Boewer C, Oldenkott B, Knauf WU, Boese-Landgraf J, Schalhorn A, Zeitz M.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 3):197-203. PubMed ID: 1557647
    [Abstract] [Full Text] [Related]

  • 16. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
    Seymour MT, Johnson PW, Hall MR, Wrigley PF, Slevin ML.
    Br J Cancer; 1994 Oct 15; 70(4):719-23. PubMed ID: 7917927
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Interferon alpha-2b, 5-fluorouracil, and folinic acid combination therapy in advanced colorectal cancer: preliminary results of a phase I/II trial.
    Schmoll HJ, Köhne-Wömpner CH, Hiddemann W, Knipp H, Wilke H, Bodenstein H, Schöffski P, Bokemeyer C, Lohrmann HP, Preiss J.
    Semin Oncol; 1992 Apr 15; 19(2 Suppl 3):191-6. PubMed ID: 1557646
    [Abstract] [Full Text] [Related]

  • 19. A phase II study of 5-fluorouracil, leucovorin, and interferon-alpha in the treatment of patients with metastatic or recurrent gastric carcinoma: an Eastern Cooperative Oncology Group study (E5292).
    Hudes GR, Lipsitz S, Grem J, Morrisey M, Weiner L, Kugler JW, Benson A.
    Cancer; 1999 Jan 15; 85(2):290-4. PubMed ID: 10023694
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.